Abstract: A method for fabricating a semiconductor device to account for misalignment includes forming a top via on a first conductive line formed on a substrate, forming liners each using a first dielectric material, including forming first and second liners to a first height along sidewalls of the top via, forming dielectric layers, including forming first and second dielectric layers on the first conductive line to the first height and adjacent to the first and second liners, respectively, recessing the top via to a second height, and forming an additional dielectric layer on the recessed top via to the first height using a second dielectric material. The first and second dielectric materials are selected to compensate for potential misalignment between the first conductive line and the top via.

Abstract: The present invention is directed to antibodies and fragments thereof having binding specificity for ACTH. Another embodiment of this invention relates to the antibodies binding fragments thereof described herein, comprising the sequences of the VH, VL and/or CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-ACTH antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention further contemplates methods of making said anti-ACTH antibodies and binding fragments thereof.

Abstract: Back end of line metallization structures and processes of fabricating the metallization structures generally include a top via integration scheme. The top via integration scheme integrally forms the via on top of trench. Thus, the via is fully aligned and can be of a desired critical dimension.

Abstract: Apparatus for providing breathing assistance, the apparatus including a body for positioning within an oral cavity of a user, the body defining at least one first opening for allowing airflow between lips of the user, two second openings provided in the oral cavity to allow air flow into and out of a posterior region of the oral cavity and two channels, each channel connecting a respective second opening to the at least one first opening and each channel passing at least one of at least partially along the buccal cavity and at least partially between the teeth to thereby provide an airway for the user, the airway at least partially bypassing the nasal passage and acting to replicate a healthy nasal passage and pharyngeal space.

Abstract: The present invention is directed to antibodies and fragments thereof having binding specificity for ACTH. Embodiments of this invention relate to the binding fragments of antibodies described herein, comprising the sequences of the VH, VL and/or CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates anti-ACTH antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention further contemplates methods of making said anti-ACTH antibodies and binding fragments thereof.

Abstract: Back end of line metallization structures and processes of fabricating the metallization structures generally include a top via integration scheme. The top via integration scheme integrally forms the via on top of trench. Thus, the via is fully aligned and can be of a desired critical dimension.

Abstract: The present invention is directed to antibodies and fragments thereof having binding specificity for ACTH. Another embodiment of this invention relates to the antibodies binding fragments thereof described herein, comprising the sequences of the VH, VL and/or CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-ACTH antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention further contemplates methods of making said anti-ACTH antibodies and binding fragments thereof.

Abstract: The present invention is directed to antibodies and fragments thereof having binding specificity for ACTH. Embodiments of this invention relate to the binding fragments of antibodies described herein, comprising the sequences of the VH, VL and/or CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates anti-ACTH antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention further contemplates methods of making said anti-ACTH antibodies and binding fragments thereof.

Abstract: The present invention is directed to antibodies and fragments thereof having binding specificity for PCSK9. Another embodiment of this invention relates to the antibodies described herein, and binding fragments thereof, comprising the sequences of the VH, VL and CDR polypeptides described herein, and the polynucleotides encoding them. The invention also contemplates conjugates of anti-PCSK9 antibodies and binding fragments thereof conjugated to one or more functional or detectable moieties. The invention also contemplates methods of making said anti-PCSK9 antibodies and binding fragments thereof. Embodiments of the invention also pertain to the use of anti-PCSK9 antibodies, and binding fragments thereof, for the diagnosis, assessment and treatment of diseases and disorders associated with PCSK9.

Abstract: An interconnect structure is provided that includes an interconnect level that contains an interconnect dielectric material layer having a first electrically conductive via feature, an electrically conductive line feature, and a second electrically conductive via feature embedded in the interconnect dielectric material layer, wherein the first and second via features are self-aligned perpendicularly to, and along the direction of, the electrically conductive line feature.

Abstract: A stent graft including a tubular wall with at least one fenestration including a peripheral reinforcement around at least part of the fenestration. There can also be a tubular extension. The side arm includes a stent and a cover and extends from and is in fluid communication with the fenestration and the stent graft. The stent may be a self expanding stent. The ring and/or tubular extension provides better support and sealing for an extension arm. The fenestration can be circular or if towards the ends of the stent graft may be in the form of a U-shape with an open end.

Abstract: An interconnect structure is provided that includes an interconnect level that contains an interconnect dielectric material layer having a first electrically conductive via feature, an electrically conductive line feature, and a second electrically conductive via feature embedded in the interconnect dielectric material layer, wherein the first and second via features are self-aligned perpendicularly to, and along the direction of, the electrically conductive line feature.

Abstract: Semiconductor devices including skip via structures and methods of forming the skip via structure include interconnection between two interconnect levels that are separated by at least one other interconnect level, i.e., skip via to connect Mx and Mx+2 interconnect levels, wherein a portion of the intervening metallization level (MX+1) is in a pathway of the skip via.

Abstract: The present disclosure relates to an improved formulation comprising at least one water soluble active ingredient and at least one penetration enhancer. The present disclosure also relates to a use of an improved formulation comprising at least one water soluble active ingredient and at least one penetration enhancer for preventing, combating or controlling pests, particularly insect infestations, by tree injection.

Abstract: A catheter assembly comprises a first elongate tubular member having a proximal end portion defining a proximal end, a distal end portion having an opening therein and defining a distal end, and at least one lumen defined between the proximal end and the distal end. A second elongate tubular member has a proximal end portion defining a proximal end, a distal end portion defining a distal end, and at least one lumen defined between the proximal end and the distal end. The second elongate tubular member is received within the at least one lumen of the first elongate tubular member, such that the distal end portion of the second elongate tubular member projects from the opening in the distal end portion of the first elongate tubular member. An elongate, shape-imparting element is receivable in the at least one lumen of at least one of the first elongate tubular member and the second elongate tubular member.

Abstract: The present disclosure relates to an improved formulation comprising at least one water soluble active ingredient and at least one penetration enhancer. The present disclosure also relates to a use of an improved formulation comprising at least one water soluble active ingredient and at least one penetration enhancer for preventing, combating or controlling pests, particularly insect infestations, by tree injection.

Abstract: A catheter sheath for an irrigation catheter comprises an elongate member having a proximal end and a distal end and defining a lumen extending from the proximal end to the distal end. At least one electrode is arranged on the elongate member. A plurality of elongate elements are contained in the elongate member, the elongate elements comprising at least one electrical conductor and at least one element of a non-conductive material arranged adjacent the at least one electrical conductor to form at least one non-conductive region associated with the elongate member. At least one passage extends through a wall of the elongate member to intersect the non-conductive region and to be in communication with the lumen of the elongate member. The at least one passage has an outlet opening in, or adjacent, the at least one electrode.

Abstract: A catheter assembly comprises a first elongate tubular member having a proximal end portion defining a proximal end, a distal end portion having an opening therein and defining a distal end, and at least one lumen defined between the proximal end and the distal end. A second elongate tubular member has a proximal end portion defining a proximal end, a distal end portion defining a distal end, and at least one lumen defined between the proximal end and the distal end. The second elongate tubular member is received within the at least one lumen of the first elongate tubular member, such that the distal end portion of the second elongate tubular member projects from the opening in the distal end portion of the first elongate tubular member. An elongate, shape-imparting element is receivable in the at least one lumen of at least one of the first elongate tubular member and the second elongate tubular member.

Abstract: A catheter assembly comprises a first elongate tubular member having a proximal end portion defining a proximal end, a distal end portion having an opening therein and defining a distal end, and at least one lumen defined between the proximal end and the distal end. A second elongate tubular member has a proximal end portion defining a proximal end, a distal end portion defining a distal end, and at least one lumen defined between the proximal end and the distal end. The second elongate tubular member is received within the at least one lumen of the first elongate tubular member, such that the distal end portion of the second elongate tubular member projects from the opening in the distal end portion of the first elongate tubular member. An elongate, shape-imparting element is receivable in the at least one lumen of at least one of the first elongate tubular member and the second elongate tubular member.

Abstract: A catheter handle includes a handle body. A steering control mechanism is displaceably carried on the handle body. An electrode sheath carrier is carried on the handle body, the electrode sheath carrier being displaceable at least relative to the steering control mechanism.